NCT00512473View on ClinicalTrials.gov

Growth Hormone Signaling in Vivo in Humans

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

April 30, 2006

Conditions
Intracellular Signaling Peptides and Proteins
Interventions
DRUG

Saline infusion

0.9 % NaCl

DRUG

Human Growth Hormone

0.5 mg genotropin administered as a bolus at t = 0

DRUG

Pegvisomant

30 mg Somavert administered at t = - 36 hours

Trial Locations (1)

8000

Medical Research Laboratories, Aarhus

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT00512473 - Growth Hormone Signaling in Vivo in Humans | Biotech Hunter | Biotech Hunter